论文部分内容阅读
目前英国已将70年代制订的风疹选择性免疫计划(只对10～14岁的学龄女孩和易感的育龄妇女提供风疹疫苗)扩大到对所有学龄前儿童(不分性别)提供麻疹、流行性腮腺炎和风疹(MMR)联合疫苗。这是因为尽管风疹易感的妇女人数在不断减少,但母亲中的风疹病例和胎儿先天获得的疾病仍在持续发生。本计划的成功不仅取决于在学龄前儿童中的高接种率,也依赖于疫苗诱导的免疫力至少持续40年。这样,在无风疹传播的情况下,抗体水平就不会由于自然再感染而被提
Currently, the United Kingdom has extended the rubella selective immunization program (which provides rubella vaccine only to school-age girls 10-14 years of age and susceptible women of child-bearing age) formulated in the 1970s to provide measles and epidemics to all preschool children (regardless of sex) Mumps and Rubella (MMR) combination vaccine. This is because although the number of women susceptible to rubella is declining, the number of rubella cases among mothers and the acquired diseases of the fetus persists. The success of this program depends not only on the high vaccination rates among preschool children but also on the vaccine-induced immunity for at least 40 years. In this way, in the absence of rubella transmission, antibody levels will not be raised by natural re-infection